Suppression of Polo like kinase 1 (PLK1) by p21Waf1 mediates the p53-dependent prevention of caspase-independent mitotic death

Cellular Signalling

Volumn 23, Issue 11, 2011, Pages 1816-1823

  Lin, Yi Cheng ^a   Sun, Synthia H ^a   Wang, Fung Fang ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Caspase independent mitotic catastrophe; P21Waf1; P53; Plk1; Polyploidy

Indexed keywords

CASPASE; CYCLIN DEPENDENT KINASE INHIBITOR 1; DOXORUBICIN; POLO LIKE KINASE 1; PROTEIN P53;

ARTICLE; CELL PROTECTION; CELL STRESS; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MITOSIS; POLYPLOIDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

BLOTTING, WESTERN; CASPASES; CELL CYCLE PROTEINS; CELL DEATH; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOXORUBICIN; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HEK293 CELLS; HUMANS; LENTIVIRUS; LUCIFERASES; LUNG NEOPLASMS; MITOSIS; POLYPLOIDY; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80051474344     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2011.06.016     Document Type: Article

References (42)

1. Malumbres M., Barbacid M. Nat. Rev. Cancer 2009, 9(3):153-166.
2. Niida H., Nakanishi M. Mutagenesis 2006, 21(1):3-9.
3. van Vugt M.A., Brás A., Medema R.H. Mutat. Res. 2010, 704(1-3):2-11.
4. Chow J., Poon R.Y. Adv. Exp. Med. Biol. 2010, 676:57-71.
5. Smith J., Tho L.M., Xu N., Gillespie D.A. Adv. Cancer Res. 2010, 108:73-112.
6. Nakanishi M., Shimada M., Niida H. Cancer Sci. 2006, 97(10):984-989.
7. Castedo M., Perfettini J.L., Roumier T., Andreau K., Medema R., Kroemer G. Oncogene 2004, 23(16):2825-2837.
8. Ricci M.S., Zong W.X. Oncologist 2006, 11(4):342-357.
9. van Vugt M.A., Medema R.H. Oncogene 2005, 24(17):2844-2859.
10. Kang Y.H., Park C.H., Kim T.S., Soung N.K., Bang J.K., Kim B.Y., Park J.E., Lee K.S. J. Biol. Chem. 2011, 286(22). 19774-19757.
11. Nilsson I., Hoffmann I. Prog. Cell Cycle Res. 2000, 4:107-114.
12. Ruiz E.J., Vilar M., Nebreda A.R. Curr. Biol. 2010, 20(8):717-723.
13. van Vugt M.A., Brás A., Medema R.H. Mol. Cell 2004, 15(5):799-811.
14. Barr F.A., Silljé H.H., Nigg E.A. Nat. Rev. Mol. Cell Biol. 2004, 5(6):429-440.
15. Smits V.A., Klompmaker R., Arnaud L., Rijksen G., Nigg E.A., Medema R.H. Nat. Cell Biol. 2000, 2(9):672-676.
16. Anger M., Kues W.A., Klima J., Mielenz M., Kubelka M., Motlik J., Esner M., Dvorak P., Carnwath J.W., Niemann H. Mol. Reprod. Dev. 2003, 65(3). 254-253.
17. Eckerdt F., Strebhardt K. Cancer Res. 2006, 66(14):6895-6898.
18. Jang Y.J., Ji J.H., Choi Y.C., Ryu C.J., Ko S.Y. J. Biol. Chem. 2007, 282(4):2473-2482.
19. Lee H.J., Hwang H.I., Jang Y.J. Cell Cycle 2010, 9(12):2389-2398.
20. McKenzie L., King S., Marcar L., Nicol S., Dias S.S., Schumm K., Robertson P., Bourdon J.C., Perkins N., Fuller-Pace F., Meek D.W. Cell Cycle 2010, 9(20):4200-4212.
21. Zhu H., Chang B.D., Uchiumi T., Roninson I.B. Cell Cycle 2002, 1(1):59-66.
22. Takai N., Hamanaka R., Yoshimatsu J., Miyakawa I. Oncogene 2005, 24(2):287-291.
23. Chopra P., Sethi G., Dastidar S.G., Ray A. Expert. Opin. Investig. Drugs 2010, 19(1):27-43.
24. Degenhardt Y., Lampkin T. Clin. Cancer Res. 2010, 16(2):384-389.
25. Sancar A., Lindsey-Boltz L.A., Unsal-Kaçmaz K., Linn S. Annu. Rev. Biochem. 2004, 73:39-85.
26. Oren M. Cell Death Differ. 2003, 10(4):431-442.
27. Vogelstein B., Lane D., Levine A.J. Nature 2000, 408(6810):307-310.
28. Friedlander P., Haupt Y., Prives C., Oren M. Mol. Cell. Biol. 1996, 16(9):4961-4971.
29. Lo P.K., Huang S.Z., Chen H.C., Wang F.F. Cancer Res. 2004, 64(23):8736-8745.
30. Lin Y.C., Wang F.F. Cell. Signal. 2008, 20(1):258-267.
31. Amaral J.D., Xavier J.M., Steer C.J., Rodrigues C.M. Curr. Pharm. Des. 2010, 16(22):2493-2503.
32. Portugal J., Mansilla S., Bataller M. Curr. Pharm. Des. 2010, 16(1):69-78.
33. Vakifahmetoglu H., Olsson M., Zhivotovsky B. Cell Death Differ. 2008, 15(7):1153-1162.
34. Ando K., Ozaki T., Yamamoto H., Furuya K., Hosoda M., Hayashi S., Fukuzawa M., Nakagawara A. J. Biol. Chem. 2004, 279(24):25549-25561.
35. Funk W.D., Pak D.T., Karas R.H., Wright W.E., Shay J.W. Mol. Cell. Biol. 1992, 12(6):2866-2871.
36. Mansilla S., Priebe W., Portugal J. Cell Cycle 2006, 5(1):53-60.
37. Datta N.S., Williams J.L., Caldwell J., Curry A.M., Ashcraft E.K., Long M.W. Mol. Biol. Cell 1996, 7(2):209-223.
38. Roh M., Song C., Kim J., Abdulkadir S.A. J. Biol. Chem. 2005, 280(49):40568-40577.
39. Yin X.Y., Grove L., Datta N.S., Katula K., Long M.W., Prochownik E.V. Cancer Res. 2001, 61(17):6487-6493.
40. Innocente S.A., Lee J.M. FEBS Lett. 2005, 579(5):1001-1007.
41. Yun J., Chae H.D., Choy H.E., Chung J., Yoo H.S., Han M.H., Shin D.Y. J. Biol. Chem. 1999, 274(42):29677-29682.
42. Vitale I., Senovilla L., Jemaà M., Michaud M., Galluzzi L., Kepp O., Nanty L., Criollo A., Rello-Varona S., Manic G., Métivier D., Vivet S., Tajeddine N., Joza N., Valent A., Castedo M., Kroemer G. EMBO J. 2010, 29(7):1272-1284.